RE: 25p + Next Hopefully.24 Mar 2020 20:16
Thoth,
"revenues will be floored by the cancellation of non urgent appointments. "
Why would revenues be floored by the cancellation of non-urgent appointments?
You seem to have a problem with understanding the business and how they operate.
The NHS has cancelled appoints all the time, it's nothing new.
TLY only opened the subsidiary Totally Healthcare (THC) last Oct, so it's a new business still being setup. Their revenues for a 3 month period was £750k. As it's a new subsidiary, their costs during the setup stage would be minimal.
With cancelled operations for this division, they are likely to lose additional £750k - £1.5m revenue they would have received. This would have been a bonus.
I am expecting TLY's revenues to be £100m++, therefore £1m reduction from what was a 'bonus' is nothing in the scheme of things.
If anything, those non-essential operations which are cancelled will be rescheduled at a later date. The big plus for TLY is that it gives them TIME to complete their setup of the THC service to more UK & Ireland sites, so they should be able to pick up more business when Covid-19 outbreak is over.
You seem to forget that THC is just one subsidiary within TLY group.
Others include Greenbrook, Vocare, Premier Health, Optimum, MyClinical, About Health and of course Totally Health.
So you believe 1 recent startup will floor revenues... Really!!
It's interesting that you think Byot at £22m is cheap but TLY at £17m is not, especially TLY has 100m revenue, where Byot just announced orders of £1.7m, so TLY is some 100x more...
Further TLY is in the right place at the right time, whereas Byot can't even keep a UK supermarket contract, having lost the Tesco contract not long ago.
Sign In
Follow the stocks
